Quick Order

Home>VEGFA
Text Size:AAA

VEGF/VEGFA/VEGF165  Protein, Antibody, ELISA Kit, cDNA Clone

Description: Active  
Expression host: Baculovirus-Insect Cells  
11066-HNAB-500
11066-HNAB-5
11066-HNAB-20
11066-HNAB-100
11066-HNAB-1
500 µg 
5 µg 
20 µg 
100 µg 
1 mg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: Baculovirus-Insect Cells  
10008-HNAB-500
10008-HNAB-5
10008-HNAB-20
10008-HNAB-100
10008-HNAB-1
500 µg 
5 µg 
20 µg 
100 µg 
1 mg 
Add to Cart
  • Slide 1
Expression host: Human Cells  
10008-HNAH-20
10008-HNAH-10
20 µg 
10 µg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: Human Cells  
11066-HNAH-500
11066-HNAH-5
11066-HNAH-20
11066-HNAH-100
11066-HNAH-1
500 µg 
5 µg 
20 µg 
100 µg 
1 mg 
Add to Cart
  • Slide 1
Expression host: Human Cells  
15692-HNAH-50
15692-HNAH-20
50 µg 
20 µg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: Baculovirus-Insect Cells  
50159-MNAB-500
50159-MNAB-5
50159-MNAB-20
50159-MNAB-100
50159-MNAB-1
500 µg 
5 µg 
20 µg 
100 µg 
1 mg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: Baculovirus-Insect Cells  
80006-RNAB-5
80006-RNAB-20
80006-RNAB-100
5 µg 
20 µg 
100 µg 
Add to Cart
  • Slide 1
Expression host: Human Cells  
70004-DNAH-20
70004-DNAH-10
20 µg 
10 µg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: Baculovirus-Insect Cells  
63004-ZNAB-5
63004-ZNAB-20
63004-ZNAB-100
5 µg 
20 µg 
100 µg 
Add to Cart
  • Slide 1

VEGF/VEGFA/VEGF165 Related Area

VEGF/VEGFA/VEGF165 Related Pathways

VEGF/VEGFA/VEGF165 Related Protein, Antibody, cDNA Gene, and ELISA Kits

Featured Reagent Products

VEGF/VEGFA/VEGF165 Summary & Protein Information

VEGF/VEGFA/VEGF165 Background

Subunit structure: Homodimer; disulfide-linked. Also found as heterodimer with PGF (By similarity). {ECO:0000250}.
Subcellular location: Secreted {ECO:0000269|PubMed:11563986, ECO:0000269|PubMed:11731620, ECO:0000269|PubMed:15896327}. Note=VEGF121 is acidic and freely secreted. VEGF165 is more basic, has heparin-binding properties and, although a signicant proportion remains cell-associated, most is freely secreted. VEGF189 is very basic, it is cell-associated after secretion and is bound avidly by heparin and the extracellular matrix, although it may be released as a soluble form by heparin, heparinase or plasmin.
Tissue specificity: Isoform VEGF189, isoform VEGF165 and isoform VEGF121 are widely expressed. Isoform VEGF206 and isoform VEGF145 are not widely expressed. A higher level expression seen in pituitary tumors as compared to the pituitary gland. {ECO:0000269|PubMed:22009797}.
Induction: By hypoxia. Regulated by growth factors, cytokines, gonadotropins, nitric oxide, hypoglycemia and oncogenic mutations. {ECO:0000269|PubMed:22009797}.
Involvement in disease: DISEASE: Microvascular complications of diabetes 1 (MVCD1) [MIM:603933]: Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
Sequence similarity: Belongs to the PDGF/VEGF growth factor family. {ECO:0000305}.
General information above from UniProt

Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.

VEGF/VEGFA/VEGF165 Alternative Name

VEGF/VEGFA/VEGF165 Related Studies

  • Woolard J. et al. (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64(21): 7822-7835.
  • Jia SF, et al. (2008) VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells. J Exp Ther Oncol. 7(2): 89-97.
  • Cimpean AM, et al. (2008) Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma. Rom J Morphol Embryol. 49(3): 303-8.
  • Hamdollah Zadeh MA, et al. (2008) VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6. Microcirculation. 15(7): 605-14.
  • Eisenach PA, et al. (2010) MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src. J Cell Sci. 123(Pt 23):4182-4193.
  • Claesson-Welsh L (2010) Gremlin: vexing VEGF receptor agonist. Blood. 116(18):3386-7.
  • Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"